Bristol-Myers Squibb Company(BMY)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BMY | 139.09 B | 15.00x | 5.70% | 18.87% | $4.54 | 46.60% | 2.02 | 3.78% | - | - |
LLY | 1.03 T | 39.47x | 47.70% | 33.53% | $29.38 | 1.02% | 1.62 | 59.00% | - | - |
JNJ | 670.99 B | 32.53x | 6.60% | 21.48% | $8.56 | 25.74% | 0.58 | 2.00% | - | - |
MRK | 375.85 B | 121.87x | 5.10% | 4.77% | $1.25 | 6.96% | 1.28 | 2.29% | - | - |
PFE | 164.21 B | 37.91x | 2.60% | 6.80% | $0.76 | 5.01% | 0.74 | 6.15% | - | - |
Peer Valuation & Performance Analysis
Peer group analysis for Bristol-Myers Squibb Company (BMY) compared to its primary competitors (including LLY, JNJ, MRK) reveals distinct metrics. BMY trades at a valuation discount relative to its competitors, with a P/E ratio of 15.0x versus the peer average of 57.9x (representing a 74% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BMY's revenue growth of 5.7% lags behind the peer average of 15.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 18.9% compared to the peer average of 16.6%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BMY ranks #1 in P/E ratio, #3 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $68.08 | $68.24 | $66.62 | $68.09 | 6,224,000 | +0.01% |
| 2026-09-02 | $66.82 | $67.73 | $66.75 | $67.66 | 7,823,700 | +1.26% |
| 2026-09-01 | $67.58 | $68.04 | $66.65 | $66.92 | 6,933,300 | -0.98% |
| 2026-08-31 | $66.25 | $67.20 | $65.91 | $66.81 | 12,681,800 | +0.85% |
| 2026-08-28 | $66.77 | $66.84 | $66.19 | $66.58 | 5,542,900 | -0.28% |
| 2026-08-27 | $66.59 | $67.47 | $66.20 | $66.95 | 4,667,100 | +0.54% |
| 2026-08-26 | $67.74 | $68.00 | $67.32 | $67.57 | 7,511,200 | -0.25% |
| 2026-08-25 | $66.42 | $68.05 | $66.42 | $67.92 | 7,911,500 | +2.26% |
| 2026-08-24 | $67.41 | $67.41 | $66.45 | $67.28 | 6,812,100 | -0.19% |
| 2026-08-21 | $65.79 | $67.55 | $65.13 | $67.01 | 6,841,300 | +1.85% |
| 2026-08-20 | $67.23 | $67.54 | $65.45 | $65.47 | 9,489,600 | -2.62% |
| 2026-08-19 | $66.80 | $68.64 | $66.61 | $67.61 | 13,882,100 | +1.21% |
| 2026-08-18 | $65.30 | $66.38 | $65.00 | $66.05 | 9,413,800 | +1.15% |
| 2026-08-17 | $63.60 | $64.74 | $63.36 | $64.63 | 7,288,800 | +1.62% |
| 2026-08-14 | $64.13 | $64.33 | $63.35 | $63.83 | 7,528,400 | -0.47% |
Explore More Analysis for BMY
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.